BCL2L13 blocking peptide product blog
Tags: BCL2L13; Blocking Peptide; BCL2L13 blocking peptide;
The BCL2L13 bcl2l13 (Catalog #MBS9227346) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The BCL2L13 bcl2l13 product has the following accession number(s) (GI #23396740) (NCBI Accession #Q9BXK5.1) (Uniprot Accession #Q9BXK5). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
May promote the activation of caspase-3 and apoptosis.
Cellular Location: Isoform 2: Mitochondrion membrane; Single-pass membrane protein. Nucleus. Tissue Location: Ubiquitous, with the highest levels of expression in heart, placenta and pancreas. Blood, Bone Marrow, Brain, Eye, Heart, Kidney, Lung, Lymph, Lymph Node, Muscle tissues are correlated with this protein. Adenocarcinoma, Asthma, Brain Diseases, Cardiovascular Diseases, Inflammation, Neoplasms, Experimental are some of the diseases may be linked to BCL2L13 Antibody (Center) Blocking Peptide. The following patways have been known to be associated with this gene.